Patients with chronic kidney disease (CKD) exhibit tremendously elevated risk for
cardiovascular disease, particularly ischemic heart disease, due to premature vascular and …

A large amount of evidence supports the widespread use of transcatheter aortic valve
replacement (TAVR) among patients who are at low to intermediate risk for surgery …

Objectives This study sought to develop and compare an array of machine learning methods
to predict in-hospital mortality after transcatheter aortic valve replacement (TAVR) in the …

Aims To assess the contemporary trends in aortic stenosis (AS) interventions in the USA
before and after the introduction of transcatheter aortic valve implantation (TAVI). Methods …

Importance Data on the burden of new-onset atrial fibrillation after transcatheter aortic valve
implantation (TAVI) and surgical aortic valve replacement (AVR) is limited mostly to small …

Transcatheter aortic valve replacement (TAVR) has gained over time a major reduction in
procedural complications. Despite this, clinically relevant bleeding still occurs in a non …

Background Acute kidney injury (AKI) after transcatheter aortic valve replacement (TAVR) is
associated with increased mortality. However, it is controversial whether AKI affects …

Aortic stenosis (AS) and regurgitation (AR) may be treated with surgical aortic valve
replacement (SAVR), transcatheter AVR (TAVR), or medical therapy (MT). Data are lacking …

Background We sought to study longer term survival in patients with aortic stenosis (AS) and
nondialysis chronic kidney disease (CKD). Methods and Results We studied 839 patients …

Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) for a failing prosthesis is
an appealing alternative to redo surgical AVR. We utilized data from the US National …